Effect of tamoxifen and raloxifene on the conjugation of bile acids with taurine and glycine in ovariectomized rats

Pharmacological Reports

Volumn 58, Issue 3, 2006, Pages 435-438

  Czerny, Bogusław ^a   Teister, Maria ^a   Juzyszyn, Zygmunt ^a   Kamiński, Adam ^a   Pawlik, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bile acids; Gallstones; Raloxifene; Tamoxifen

Indexed keywords

BILE ACID CONJUGATE; CARBON 14; CHOLESTEROL; GLYCINE; RALOXIFENE; TAMOXIFEN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN DEFICIENCY; FEMALE; NONHUMAN; OVARIECTOMY; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; THIN LAYER CHROMATOGRAPHY;

EID: 33746345016     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Akin ML, Uluutku H, Erenoglu C, Karadag A, Gulluoglu BM, Sakar B, Celenk T: Tamoxifen and gallstone formation in postmenopausal breast cancer patients: retrospective cohort study. World Surg, 2003, 27, 395-399.
2. Czerny B, Pawlik A, Juzyszyn Z, Myśliwiec Z: Effect of tamoxifen on bone mineral density and blood lipids in ovariectomized rats. Pol J Pharmacol, 2003, 55, 1137-1142.
3. 14C-cholesterol to bile acids. Pharm Rep, 2005, 57, 896-900.
4. Diehl AK: Epidemiology and natural history of gallstone disease. Gastroenterol Clin N Am, 1991, 20, 1-19.
5. Everson GT, McKinley C, Kern F Jr: Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest, 1991, 87, 237-246.
6. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB et al.: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst, 2005, 97, 1652-1662.
7. Gilloteaux J, Karkare S, Don AQ, Sexton RC: Cholelithiasis-induced in the Syrian hamster: evidence for an intramucinous nucleating process and down regulation of cholesterol 7 alpha-hydroxylase (CYP7) gene by medroxyprogesterone. Microsc Res Technique, 1997, 39, 56-70.
8. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B: Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest, 1989, 84, 811-816.
9. Holzbach RT, Kibe A, Thiel E, Howell JH, Marsh M, Hermann RE: Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest, 1984, 73, 35-45.
10. Honoré LH: Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study. J Reprod Med, 1980, 25, 187-190.
11. Johnston DE, Kaplan MM: Pathogenesis and treatment of gallstones. N Engl J Med, 1993, 328, 412-421.
12. Jordan VC, Gapstur S, Morrow M: Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 2001, 93, 1449-1457.
13. Messa C, Maselli MA, Cavallini A, Caruso ML, Pezzolla F, Di Leo A: Sex steroid hormone receptors and human gallbladder motility in vitro. Digestion, 1990, 46, 214-219.
14. Paumgartner G, Sauerbruch T: Gallstones: pathogenesis. Lancet, 1991, 338, 1117-1121.
15. Stone BG, Erickson SK, Craig WY, Cooper AD: Regulation of rat biliary cholesterol secretion by agents that alter intrahepatic cholesterol metabolism. J Clin Invest, 1985, 76, 1773-1781.